Insmed Incorporated (INSM)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Insmed Incorporated, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Insmed Incorporated (INSM) has returned -6.04% so far this year and 114.34% over the past 12 months. Looking at the last ten years, INSM has achieved an annualized return of 29.16%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Jun 1, 2000, INSM's average daily return is +0.14%, while the average monthly return is +3.08%. At this rate, your investment would double in approximately 1.9 years.

Historically, 49% of months were positive and 51% were negative. The best month was Sep 2017 with a return of +151.3%, while the worst month was Sep 2002 at -77.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.

On a daily basis, INSM closed higher 47% of trading days. The best single day was Sep 5, 2017 with a return of +119.6%, while the worst single day was Sep 10, 2002 at -70.2%.

Insmed Incorporated has an annualized alpha of 33.02%, beta of 0.93, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since June 02, 2000.

• This stock participated in 148.43% of S&P 500 Index downside but only 137.30% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

INSM ranks 88 for risk / return — in the top 88% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Insmed Incorporated (INSM) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Insmed Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Insmed Incorporated was 98.65%, occurring on Nov 25, 2011. Recovery took 3514 trading sessions.

The current Insmed Incorporated drawdown is 22.65%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Insmed Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Insmed Incorporated is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.